Skip to content
Governance Register

← US public companies

Trevi Therapeutics, Inc.

SEC CIK 1563880 · TRVI · last insider filing 2026-06-04

Directors (from insider filings)

NameCapacity as filedFilings
Vanlent Anne Director filed 2019 - 2026
Colangelo Dominick Director filed 2020 - 2026
Mathers Edward T Director filed 2019 - 2026
Meeker David P Director filed 2019 - 2026
Heffernan Michael Thomas Director filed 2019 - 2026
Good Jennifer L Director · See Remarks filed 2019 - 2026
Cassella James V Director · Chief Development Officer filed 2020 - 2026
Walker Paul Edward Director filed 2019 - 2026
Agger Mette Kirstine Director filed 2019 - 2019
Mitsak Anna Guyer Director filed 2019 - 2019
Nadav Eran Director filed 2019 - 2019

Officers (from insider filings)

NameTitle as filedFilings
Sciascia Thomas Chief Scientific Officer filed 2019 - 2026
Galletta Christopher See Remarks filed 2021 - 2026
Simon Farrell Chief Commercial Officer filed 2023 - 2026
Hastings David C Chief Financial Officer filed 2026 - 2026
Delfini Lisa Chief Financial Officer filed 2021 - 2025
Clark David J Chief Medical Officer filed 2022 - 2024
Forbes William P Chief Development Officer filed 2021 - 2022
Muscolo Frank P Controller filed 2019 - 2021
Seiter Christopher Chief Financial Officer filed 2019 - 2021
Mazabraud Yann See Remarks filed 2019 - 2020
Brett-Smith Helena Chief Development Officer filed 2019 - 2020

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.